Bausch & Lomb Corp (BLCO)
$17.15+$0.02 (+0.12%) Today
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 3 | 71,459 | $1.19M |
| Grant or award | 10 | 464,719 | |
| Tax withholding / forfeiture | 2 | 5,239 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
86 Form 4 filings on record, the earliest from Oct 1, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Barbara Trebbi - Director | Grant or award | Common Shares, No Par Value | 11,776 | $0.00 | - | |
| Laurence E. Paul - Director | Grant or award | Common Shares, No Par Value | 11,776 | $0.00 | - | |
| Robert J. Chersi - Director | Grant or award | Common Shares, No Par Value | 11,776 | $0.00 | - | |
| Frederick Munsch - Officer | Open-market sale | Common Shares, No Par Value | 52,900 | $16.78 | $888K | |
| Eschenbach Andrew C. von - Director | Open-market sale | Common Shares, No Par Value | 12,500 | $16.50 | $206K | |
| Eschenbach Andrew C. von - Director | Open-market sale | Common Shares, No Par Value | 6,059 | $16.58 | $100K | |
| Andrew J. Stewart - Officer | Grant or award | Common Shares, No Par Value | 16,778 | $0.00 | - | |
| Frederick Munsch - Officer | Grant or award | Common Shares, No Par Value | 9,091 | $0.00 | - | |
| Yehia Hashad - Officer | Grant or award | Common Shares, No Par Value | 20,973 | $0.00 | - | |
| Sam Eldessouky - Officer | Grant or award | Common Shares, No Par Value | 50,335 | $0.00 | - | |
| Luc Bonnefoy - Officer | Grant or award | Common Shares, No Par Value | 16,778 | $0.00 | - | |
| A. Robert D. Bailey - Officer | Grant or award | Common Shares, No Par Value | 33,557 | $0.00 | - | |
| Brent L. Saunders - Officer | Tax withholding / forfeiture | Common Shares, No Par Value | 4,231 | $16.76 | $71K | |
| Brent L. Saunders - Officer | Grant or award | Common Shares, No Par Value | 281,879 | $0.00 | - | |
| Luc Bonnefoy - Officer | Tax withholding / forfeiture | Common Shares, No Par Value | 1,008 | $15.08 | $15K | |
| Eschenbach Andrew C. von - Director | Grant or award | Common Shares, No Par Value | 15,842 | $15.78 | $250K | |
| Thomas W. Ross Sr. - Director | Grant or award | Common Shares, No Par Value | 15,842 | $15.78 | $250K | |
| Russel C. Robertson - Director | Grant or award | Common Shares, No Par Value | 15,842 | $15.78 | $250K | |
 John Paulson - Director | Grant or award | Common Shares, No Par Value | 15,842 | $15.78 | $250K | |
 Karen Ling - Director | Grant or award | Common Shares, No Par Value | 15,842 | $15.78 | $250K | |
| Sarah B. Kavanagh - Director | Grant or award | Common Shares, No Par Value | 15,842 | $15.78 | $250K | |
| Steven H. Collis - Director | Grant or award | Common Shares, No Par Value | 15,842 | $15.78 | $250K | |
 Nathalie D. Bernier - Director | Grant or award | Common Shares, No Par Value | 15,842 | $15.78 | $250K | |
| Eduardo Alfonso - Director | Grant or award | Common Shares, No Par Value | 15,842 | $15.78 | $250K | |
| Brent L. Saunders - Officer | Tax withholding / forfeiture | Common Shares, No Par Value | 2,886 | $15.92 | $46K | |
| Sam Eldessouky - Officer | Tax withholding / forfeiture | Common Shares, No Par Value | 63,938 | $16.00 | $1.02M | |
| Yehia Hashad - Officer | Tax withholding / forfeiture | Common Shares, No Par Value | 13,664 | $16.00 | $219K | |
| Frederick Munsch - Officer | Tax withholding / forfeiture | Common Shares, No Par Value | 8,673 | $16.00 | $139K | |
| Luc Bonnefoy - Officer | Tax withholding / forfeiture | Common Shares, No Par Value | 11,970 | $16.00 | $192K | |
| Russel C. Robertson - Director | Grant or award | Common Shares, No Par Value | 1,611 | $15.90 | $26K | |
| John Paulson - Director | Grant or award | Common Shares, No Par Value | 1,375 | $15.90 | $22K | |
| Steven H. Collis - Director | Grant or award | Common Shares, No Par Value | 1,415 | $15.90 | $22K |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Munsch Frederick | Officer | 52,900 | $888K | View on EDGAR | |
| Munsch Frederick | Former Officer | 52,900 | $888K | View on EDGAR | |
| VON ESCHENBACH ANDREW C. | Former Director | 6,059 | $100K | View on EDGAR |
Bausch & Lomb Corp (BLCO) had 13 insider filings in the last 90 days, with the most recent on 2026-08-14. The full record for BLCO runs to 86 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of BLCO were filed in the last 90 days. 10 purchases are on record for this company.
3 insider sales of BLCO were filed in the last 90 days, totaling $1.19M.
This page tracks BLCO Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add BLCO to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
